Saturday, October 20, 2018

Althea

Expanding upon our existing capabilities in biologics manufacturing, Althea is establishing itself as a premier, US-based provider for high-containment ADC bioconjugate manufacturing as well as fill and finish services for both HPAPIs and ADCs. Our state-of-the-art 57,000 sq ft...

celares GmbH

celares GmbH, established 2003, is a Contract Development and Manufacturing Organization (CDMO) providing customized services as well as innovative solutions for antibody-drug conjugates or ADCs. The company uniquely combines expertise in both synthetic and protein chemistry and has experiences in...

MabPlex

MabPlex, founded in 2013, is a specialized, global CRO/CMO service provider, offering one-stop biologics development and manufacturing solutions to customers with a services from cell line development and process development to GMP manufacturing. The company's technical expertise allows them to...

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease...

MedImmune

MedImmune, the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including oncology, respiratory disease, inflammation, autoimmunity, cardiovascular disease, metabolic disease, neuroscience, and infection and vaccines. Since...
Quanta BioDesign, Ltd.  in was founded 1997 for the purpose of developing and commercializing an extensive line of products for companies involved in drug discovery and diagnostic development programs.  The company's products are based on  proprietary discrete polyethylene glycol...

QPS Holdings

Founded in 1995, QPS is a contract research organization (CRO) that tests drug candidates for major pharmaceutical companies.  The company is GLP/GCP-compliant, supporting discovery, preclinical and clinical drug development.  As part of the services, the company provides quality services to...
Redwood Bioscience Inc., a biopharmaceutical company, engages in developing precision protein-chemical engineering technology designed for developing and optimizing the next-generation antibody-drug conjugates and other semi-synthetic biotherapeutics. The company's site specific protein modification platform provides control over cargo placement on...
Regeneron Pharmaceuticals, Inc. is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets three products in the United States, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection...
Antibody-drug conjugation (ADC) technology uses monoclonal antibodies or other biologics to deliver conjugated highly-potent APIs (HPAPIs) to targeted cells. In conjugated form, the HPAPI exhibits more selective cytotoxicity, thereby, sparing non-target cells from many of the toxic effects. For antibody...

Related articles